Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein

References

• Zhu N, Zhang DY, Wang WL, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. DOI:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. DOI:10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Coronavirus disease (COVID-19 Pandemic). Available from: www.who.int/emergencies/diseases/novel-coronavirus-2019
   Google Scholar
• World Health Organization. Coronavirus disease (COVID-19) pandemic. [accessed 2022 Jul 12]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
   Google Scholar
• Gorbalenya AE, Baker SC, Baric RS, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. DOI:10.1038/s41564-020-0695-z
   PubMed Web of Science ®Google Scholar
• Jiang S, Hillyer C, Du L, et al. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41(5):355–359. DOI:10.1016/j.it.2020.03.007
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. DOI:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status. Military Med Res. 2020;7(11):99–109. DOI:10.1186/s40779-020-00240-0
   Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. New York: Coronaviruses; 2015.
   Google Scholar
• Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. DOI:10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Tai WB, He L, Zhang XJ, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020;17(6):613–620. DOI:10.1038/s41423-020-0400-4
   PubMed Web of Science ®Google Scholar
• Tian YY, Zhang GP, Liu HL, et al. Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies. Appl Microbiol Biotechnol. 2022;106(3):1151–1164. DOI:10.1007/s00253-022-11769-6
   PubMed Web of Science ®Google Scholar
• Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16:69, DOI:10.1186/s12985-019-1182-0
   PubMed Web of Science ®Google Scholar
• Luo YY, Guo XL, Yan HJ, et al. Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM. Appl Microbiol Biotechnol. 2015;99:5917–5927. DOI:10.1007/s00253-015-6538-9
   PubMed Web of Science ®Google Scholar
• Wang MY, Zhao R, Gao LJ, et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269, DOI:10.3389/fcimb.2020.587269
   PubMed Web of Science ®Google Scholar
• Sternberg A, Naujokat C. Structural features of coronavirus SARS-CoV-2 spike protein: targets for vaccination. Life Sci. 2020;257:118056. DOI:10.1016/j.lfs.2020.118056
   PubMed Web of Science ®Google Scholar
• Du LY, He YX, Zhou YS, et al. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226–236. DOI:10.1038/nrmicro2090
   PubMed Web of Science ®Google Scholar
• Babu PVC, Srinivas VK, Mohan VK, et al. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli. J Chromatogr B Analyt Technol Biomed Life. 2008;861(2):218–226. DOI:10.1016/j.jchromb.2007.10.008
   PubMed Web of Science ®Google Scholar
• Jiang M, Guo JQ, Zhang GP, et al. Fine mapping of linear B cell epitopes on capsid protein of porcine circovirus 3. Appl Microbiol Biotechnol. 2020;104(14):6223–6234. DOI:10.1007/s00253-020-10664-2
   PubMed Web of Science ®Google Scholar
• Xie CJ, Wang RZ, Saeed AFUH, et al. Preparation of anti-human podoplanin monoclonal antibody and its application in immunohistochemical diagnosis. Sci Rep. 2018;8(1):10162–10172. DOI:10.1038/s41598-018-28549-w
   PubMedGoogle Scholar
• Liu YC, Wang JC, Chen YM, et al. Identification of a dominant linear epitope on the VP2 capsid protein of porcine parvovirus and characterization of two monoclonal antibodies with neutralizing abilities. Int J Biol Macromol. 2020;163:2013–2022. DOI:10.1016/j.ijbiomac.2020.09.055
   PubMed Web of Science ®Google Scholar
• Waterhouse AM, Procter JB, Martin DMA, et al. Jalview version 2 – a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25(9):1189–1191. DOI:10.1093/bioinformatics/btp033
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhang GP, Liu HL, et al. Epitope profiling reveals the critical antigenic determinants in SARS-CoV-2 RBD-based antigen. Front Immunol. 2021;12. DOI:10.3389/fimmu.2021.707977
   Web of Science ®Google Scholar
• Zhou Y, Li YS, Pan FG, et al. Development of a new monoclonal antibody based direct competitive enzyme-linked immunosorbent assay for detection of brevetoxins in food samples. Food Chem. 2010;118(2):467–471. DOI:10.1016/j.foodchem.2009.05.015
   Web of Science ®Google Scholar
• Li L, Zhou Y, Li YS, et al. Preparation of an antigen and development of a monoclonal antibody against mono-butylphthalate (MBP). Food Agric Immunol. 2012;24(2):193–202. DOI:10.1080/09540105.2012.677010
   Web of Science ®Google Scholar
• Poh CM, Carissimo G, Wang B, et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020;11(1):2806, DOI:10.1038/s41467-020-16638-2
   PubMed Web of Science ®Google Scholar
• Lugo AC, Siles ML, López D, et al. Identification and analysis of unstructured, linear B-cell epitopes in SARS-CoV-2 virion proteins for vaccine development. Vaccines. 2020;8(3):397. DOI:10.3390/vaccines8030397
   Web of Science ®Google Scholar
• Polyiam K, Phoolcharoen W, Butkhot N, et al. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay. Sci Rep. 2021;11:20383, DOI:10.1038/s41598-021-99642-w
   PubMed Web of Science ®Google Scholar
• Dawood RM, Meguid MAE, Salum GM, et al. Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2. J Infect Public Health. 2021;14(2):169–178. DOI:10.1016/j.jiph.2020.12.006
   PubMed Web of Science ®Google Scholar
• Kesarwani V, Gupta R, Vetukuri RR, et al. Identification of unique peptides for SARS-CoV-2 diagnostics and vaccine development by an in silico proteomics approach. Front Immunol. 2021;12:725240, DOI:10.3389/fimmu.2021.725240
   PubMed Web of Science ®Google Scholar
• Carmona AR, Prestel HFP, Lafuente EM, et al. BCEPS: a web server to predict linear B cell epitopes with enhanced immunogenicity and cross-reactivity. Cells. 2021;10(10):2744, DOI:10.3390/cells10102744
   PubMed Web of Science ®Google Scholar
• Lu S, Xie XX, Zhao L, et al. The immunodominant and neutralization linear epitopes for SARS-CoV-2. Cell Rep. 2021;34(4):108666, DOI:10.1016/j.celrep.2020.108666
   PubMed Web of Science ®Google Scholar
• Lan J, Ge JW, Yu JF, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–220. DOI:10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Zhang YW, Yang ZR, Tian SC, et al. A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients. BMC Microbiol. 2021;21:194, DOI:10.1186/s12866-021-02241-y
   PubMed Web of Science ®Google Scholar
• Lu XY, Hosono YK, Nagae M, et al. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients. J Exp Med. 2021;218(12):e20211327. DOI:10.1084/jem.20211327
   PubMed Web of Science ®Google Scholar